Monday, January 17, 2022

< + > The Drug Industry Might Have Dodged A Build Back Better Bullet But Remains In Congressional Crosshairs

Industry critics have managed to get a foothold with reforms that will have devastating, long-term effects for patients and drug companies alike. And worse, they were included in a bill that could actually pass via the special reconciliation process that governs federal budgeting.

No comments:

Post a Comment

< + > This Week’s Health IT Jobs – June 18, 2025

It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take t...